Algebally Ahmed Mohamed, Mohey Nesreen, Szmigielski Wojciech, Yousef Reda Ramadan Hussein, Kohla Samah
Department of Diagnostic Imaging and Nuclear Medicine, Zagazig University, Zagazig, Egypt.
Department of Clinical Imaging, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
Pol J Radiol. 2015 Mar 4;80:115-21. doi: 10.12659/PJR.892583. eCollection 2015.
The purpose of the study was to identify the accuracy of high-resolution MRI in the pre-operative assessment of mesorectal fascia involvement, circumfrential resection margin (CRM) and local staging in patients with rectal carcinoma.
MATERIAL/METHODS: The study included 56 patients: 32 male and 24 female. All patients underwent high-resolution MRI and had confirmed histopathological diagnosis of rectal cancer located within 15 cm from the anal verge, followed by surgery. MRI findings were compared with pathological and surgical results.
The overall accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of MRI-based T-staging were 92.8, 88.8%, 96.5%, 96%, and 90.3%, respectively. The accuracy, sensitivity, specificity, PPV, and NPV of MRI-based assessment of CRM were 94.6%, 84.6%, 97.6%, 91.4, and 94.6%, respectively. The accuracy, sensitivity, specificity, PPV, and NPV of MRI-based N-staging were 82.1%, 75%, 67.3%, 60%, and 86.1%, respectively.
Preoperative high-resolution rectal MRI is accurate in predicting tumor stage and CRM involvement. MRI is a precise diagnostic tool to select patients who may benefit from neo-adjuvant therapy and to avoid overtreatment in those patients who can proceed directly to surgery.
本研究的目的是确定高分辨率MRI在直肠癌患者术前评估中对直肠系膜筋膜受累、环周切缘(CRM)及局部分期的准确性。
材料/方法:本研究纳入56例患者,其中男性32例,女性24例。所有患者均接受了高分辨率MRI检查,并经组织病理学确诊为距肛缘15 cm以内的直肠癌,随后接受手术治疗。将MRI检查结果与病理及手术结果进行比较。
基于MRI的T分期的总体准确率、敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)分别为92.8%、88.8%、96.5%、96%和90.3%。基于MRI评估CRM的准确率、敏感性、特异性、PPV和NPV分别为94.6%、84.6%、97.6%、91.4%和94.6%。基于MRI的N分期的准确率、敏感性、特异性、PPV和NPV分别为82.1%、75%、67.3%、60%和86.1%。
术前高分辨率直肠MRI在预测肿瘤分期和CRM受累方面是准确的。MRI是一种精确的诊断工具,可用于选择可能从新辅助治疗中获益的患者,并避免对可直接进行手术的患者进行过度治疗。